V. Kerlan

ORCID: 0000-0001-8105-6628
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pituitary Gland Disorders and Treatments
  • Diabetes Management and Research
  • Adrenal and Paraganglionic Tumors
  • Growth Hormone and Insulin-like Growth Factors
  • Diabetes and associated disorders
  • Sexual Differentiation and Disorders
  • Neuroendocrine Tumor Research Advances
  • Diabetes Treatment and Management
  • Diabetes Management and Education
  • Adrenal Hormones and Disorders
  • Hormonal Regulation and Hypertension
  • Bone health and treatments
  • Healthcare Systems and Practices
  • Hormonal and reproductive studies
  • Health, Medicine and Society
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Ovarian function and disorders
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Reproductive Biology and Fertility
  • Glioma Diagnosis and Treatment
  • Estrogen and related hormone effects
  • Gestational Diabetes Research and Management
  • Thyroid Disorders and Treatments
  • Neuroblastoma Research and Treatments
  • Thyroid Cancer Diagnosis and Treatment

Centre Hospitalier Régional Universitaire de Brest
2016-2025

Université de Bretagne Occidentale
2013-2025

Hôpital Maison Blanche
2012-2024

Inserm
2003-2024

Service de la Santé Publique
2003-2020

Centre Hospitalier Universitaire de Caen
2019

Université de Caen Normandie
2019

Assistance Publique – Hôpitaux de Paris
2018

HRA Pharma (France)
2018

Université de Bourgogne
2015

The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects (or at risk for) type 2 diabetes mellitus are unknown.In this double-blind study a 2-by-2 factorial design, we randomly assigned 12,536 who were high for and had impaired fasting glucose, glucose tolerance, to receive 1-g capsule containing least 900 mg (90% more) ethyl esters placebo daily either insulin glargine standard care. primary outcome was death...

10.1056/nejmoa1203859 article EN New England Journal of Medicine 2012-06-14

Coronavirus disease-2019 (COVID-19) is a life-threatening infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Diabetes has rapidly emerged as major comorbidity for COVID-19 severity. However, phenotypic characteristics of diabetes in patients are unknown. We conducted nationwide multicentre observational study people with hospitalised 53 French centres period 10–31 March 2020. The primary outcome combined tracheal intubation mechanical ventilation...

10.1007/s00125-020-05180-x article EN cc-by Diabetologia 2020-05-29

What are the prevalence and outcomes of spontaneous pregnancies (SP) in a large cohort French women with Turner syndrome (TS)?Amongst 480 TS, 27 (5.6%) had total 52 SP, 30 full-term deliveries for 18 women.Primary ovarian insufficiency is classic feature TS. So far, few studies have evaluated rate SP these patients.The Ministry Health set up National Reference Centre Rare Growth Disorders (CRMERC), including We studied adult TS patients from seven endocrine units (Saint-Antoine,...

10.1093/humrep/dew012 article EN Human Reproduction 2016-02-13

Three genes encoding for mitochondrial complex II proteins are linked to hereditary paraganglioma. We have recently shown that an inactivation of the SDHD gene is associated with a complete loss activity and stimulation angiogenic pathway (Gimenez-Roqueplo, A. P., J. Favier, P. Rustin, Mourad, F. Plouin, Corvol, Rötig, X. Jeunemaitre, 2001, Am J Hum Genet 69:1186–1197). Here, we relate case malignant sporadic pheochromocytoma induced by germline missense mutation SDHB gene. Within tumor,...

10.1210/jc.2002-020525 article EN The Journal of Clinical Endocrinology & Metabolism 2002-10-01

Context Germline mutations in the aryl hydrocarbon receptor interacting protein gene ( AIP ) have been identified young patients (age ≤30 years old) with sporadic pituitary macroadenomas. Otherwise, there are few data concerning prevalence of multiple endocrine neoplasia type 1 MEN1 such a population. Objective We assessed both and genetic abnormalities (mutations large deletions) diagnosed isolated macroadenoma, without hypercalcemia and/or MEN1-associated lesions. Design The entire coding...

10.1530/eje-12-0763 article EN European Journal of Endocrinology 2013-01-16

Outcomes of congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency (21OHD) have been widely studied in children and women, but less so men.The objective was analyze data from a network metropolitan French teaching hospitals on the clinical outcome 21OHD large sample hyperplasia/21OHD-genotyped adult men, particularly impact gonadotrope axis, testicular function, fertility.From April 2011 June 2014, tertiary endocrinology departments provided for 219 men with (ages, 18-70 y;...

10.1210/jc.2014-4124 article EN The Journal of Clinical Endocrinology & Metabolism 2015-03-30

Activated protein C (APC) resistance not related to the factor V Leiden mutation is a risk for venous thrombosis. Oral estrogen replacement therapy (ERT) has been reported induce APC resistance. Little known about effect of transdermal estrogen.We enrolled 196 postmenopausal women who were randomly allocated receive either 1 mg 17beta-estradiol orally (n=63) or 50 microg transdermally per day (n=68), both associated with 100 progesterone daily placebo (n=65) 6 months. An activated partial...

10.1161/01.atv.0000087141.05044.1f article EN Arteriosclerosis Thrombosis and Vascular Biology 2003-07-22

Multiple endocrine neoplasia syndrome type 1 (MEN1), which is secondary to mutation of the MEN1 gene, a rare autosomal-dominant disease that predisposes carriers tumors. Although genotype-phenotype studies have so far failed identify any statistical correlations, some families harbor recurrent tumor patterns. The function MENIN unclear, but has been described through discovery its interacting partners. Mutations in domains functional partners shown directly alter regulation abilities. We...

10.1093/hmg/ddt039 article EN Human Molecular Genetics 2013-01-31

Familial isolated pituitary adenoma (FIPA) occurs in families and is unrelated to multiple endocrine neoplasia type 1 Carney complex. Mutations AIP account only for 15–25% of FIPA families. CDKN1B mutations cause MEN4 which affected patients can suffer from adenomas. With this study, we wanted assess whether occur among a large cohort mutation-negative kindreds. Eighty-eight were studied 124 subjects underwent sequencing . Functional analysis putative was performed using silico vitro...

10.1530/erc-11-0362 article EN Endocrine Related Cancer 2012-01-30

Adrenocortical cancer (ACC) is an aggressive tumor with a heterogeneous outcome. Prognostic stratification difficult even based on stage and Ki67. Recently integrated genomics studies have demonstrated that CpG islands hypermethylation correlated poor survival. The goal of this study was to confirm the prognostic value methylation independent cohort. Methylation measured by methylation-specific multiplex ligation–dependent probe amplification (MS-MLPA). MS-MLPA performed in training cohort...

10.1210/jc.2016-3205 article EN The Journal of Clinical Endocrinology & Metabolism 2016-12-14

Objective Somapacitan is a reversible albumin-binding growth hormone (GH) derivative, developed for once-weekly administration. This study aimed to evaluate the safety of somapacitan vs once-daily Norditropin ® . Local tolerability and treatment satisfaction were also assessed. Design 26-week randomized, controlled phase 3 trial in six countries (Nbib2382939). Methods Male or female patients aged 18–79 years with adult GH deficiency (AGHD), treated ≥6 months, randomized ( n = 61) 31)...

10.1530/eje-17-1073 article EN cc-by European Journal of Endocrinology 2018-03-03

Turner syndrome (TS; ORPHA 881) is a rare condition in which all or part of one X chromosome absent from some cells. It affects approximately every 1/2500 liveborn girls. The most frequently observed karyotypes are 45,X (40-50%) and the 45,X/46,XX mosaic karyotype (15-25%). Karyotypes with an isochromosome (45,X/46,isoXq 45,X/46,isoXp), Y chromosome, ring deletions less frequent. objective French National Diagnosis Care Protocol (PNDS; Protocole de Diagnostic et Soins) to provide health...

10.1186/s13023-022-02423-5 article EN cc-by Orphanet Journal of Rare Diseases 2022-04-01

Ketoconazole (KTZ) is one of few available treatments for Cushing's syndrome (CS). Although KTZ has been associated with severe hepatotoxicity, little information about hepatic safety in CS. The aim this study was to document changes liver function patients CS treated KTZ.An observational prospective French cohort (Compassionate Use Programme (CUP)).Enrolled were stratified into a KTZ-naive and already by another formulation ketoconazole (KTZ-switch cohort). Liver markers (alanine...

10.1530/eje-17-0886 article EN European Journal of Endocrinology 2018-02-23

<h3>Background</h3> Germline mutations in the <i>SDHD</i> tumour suppressor gene (11q23.1) predispose to phaeochromocytomas and paragangliomas (PPGL) mainly on a paternal transmission. However, PPGL have been recently reported three carriers of maternally inherited mutation. <h3>Objective</h3> To assess risk occurrence maternal transmission <h3>Methods</h3> Pedigrees 80 <i>SDHD</i>-related families reviewed. 35 asymptomatic subjects carrying transmitted mutation were identified. 20 them...

10.1136/jmedgenet-2016-104297 article EN Journal of Medical Genetics 2016-11-17

Summary C-reactive protein (CRP) is one of the main independent predictors cardiovascular events. Oral post-menopausal estro-gen replacement therapy (ERT) increases CRP levels, but effect transdermal ERT not well documented. CRP, interleukine-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels were evaluated in a randomised study 196 healthy postmenopausal women, who allocated to receive continuous oral estradiol-17β, (n=63) or (n=68) both combined with micronised progesterone, placebo...

10.1055/s-0037-1613608 article EN Thrombosis and Haemostasis 2003-01-01
Coming Soon ...